ArticleBMJ open diabetes research & care2022

Real-world use of once-weekly semaglutide in patients with type 2 diabetes: pooled analysis of data from four SURE studies by baseline characteristic subgroups.

Jean-François Yale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.